First Look Analyst Calls Briefing for Friday, November 4, 2022
Here are early analyst research calls for Friday.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Advanced Energy (AEIS) upgraded to Buy from Neutral at Citigroup; tgt lowered to $95
> Coherent (COHR) upgraded to Buy from Neutral at Citigroup; tgt lowered to $52
> Cohu (COHU) upgraded to Buy from Neutral at Citigroup; tgt raised to $45
> Karyopharm Therapeutics (KPTI) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $10
> Penumbra (PEN) upgraded to Buy from Neutral at Citigroup; tgt lowered to $212
Downgrades:
> ACADIA Pharmaceuticals (ACAD) downgraded to Sell from Neutral at Goldman; tgt lowered to $12
> Arconic (ARNC) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $22
> Aurinia Pharma (AUPH) downgraded to Perform from Outperform at Oppenheimer
> BigCommerce (BIGC) downgraded to Hold from Buy at Truist; tgt $13
> C4 Therapeutics (CCCC) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $15
> EchoStar (SATS) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $27
> Fidelity Nat’l Info (FIS) downgraded to Perform from Outperform at Oppenheimer
> Frontdoor (FTDR) downgraded to Mkt Perform from Outperform at Raymond James
> Funko (FNKO) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $16
> GoPro (GPRO) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $6
> HireRight Holdings (HRT) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $12
> MKS Instruments (MKSI) downgraded to Hold from Buy at The Benchmark Company
> Prothena (PRTA) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt raised to $55
> Spirit Aerosystems (SPR) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $29
Others:
> Allscripts Healthcare (MDRX) assumed with an Overweight at Piper Sandler; tgt $17
Contact [email protected] for any questions or corrections.
